|
Quotes & Info
|
| BPTH > SEC Filings for BPTH > Form 8-K on 30-May-2012 | All Recent SEC Filings |
30-May-2012
Other Events
On May 29, 2012, Bio-Path Holdings, Inc. issued a press release titled "Bio-Path Holdings Successfully Completes Third Cohort in Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia."
A copy of such press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
|
|